Clinical Trial Update: Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update assessing rituximab for granulomatosis with polyangiitis and microscopic polyangiitis. The study is completed with results posted in 2011…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Vasculitis, Wegener's Granulomatosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-08-25